Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 1
1988 1
1990 1
1991 2
1992 2
1994 7
1995 2
1996 2
1997 2
1998 5
1999 5
2000 3
2001 1
2002 1
2003 4
2004 1
2005 3
2006 4
2007 8
2008 3
2009 4
2010 2
2011 2
2012 4
2013 2
2014 4
2015 1
2016 1
2017 1
2018 3
2019 2
2020 3
2021 5
2022 2
2024 1
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Effects of extended-release niacin with laropiprant in high-risk patients.
HPS2-THRIVE Collaborative Group; Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, Wallendszus K, Craig M, Jiang L, Collins R, Armitage J. HPS2-THRIVE Collaborative Group, et al. N Engl J Med. 2014 Jul 17;371(3):203-12. doi: 10.1056/NEJMoa1300955. N Engl J Med. 2014. PMID: 25014686 Free article. Clinical Trial.
Comparative Pathology of the Peripheral Nervous System.
Lanigan LG, Russell DS, Woolard KD, Pardo ID, Godfrey V, Jortner BS, Butt MT, Bolon B. Lanigan LG, et al. Among authors: godfrey v. Vet Pathol. 2021 Jan;58(1):10-33. doi: 10.1177/0300985820959231. Epub 2020 Oct 5. Vet Pathol. 2021. PMID: 33016246 Review.
Tumor suppressors in Sox2-mediated lung cancers promote distinct cell-intrinsic and immunologic remodeling.
Sengottuvel N, Whately KM, Modliszewski JL, Sellers RS, Green WD, Gong W, Woods AT, Livingston EW, Fagan-Solis KD, Cannon G, Edatt L, Yuan H, Chack AC, Sanchez Y, Zhou K, Dawoud A, Green JM, Godfrey V, Milner JJ, Gupta GP, Pecot CV. Sengottuvel N, et al. Among authors: godfrey v. JCI Insight. 2025 May 6;10(12):e171364. doi: 10.1172/jci.insight.171364. eCollection 2025 Jun 23. JCI Insight. 2025. PMID: 40327401 Free PMC article.
Pathology of mouse models of intestinal cancer: consensus report and recommendations.
Boivin GP, Washington K, Yang K, Ward JM, Pretlow TP, Russell R, Besselsen DG, Godfrey VL, Doetschman T, Dove WF, Pitot HC, Halberg RB, Itzkowitz SH, Groden J, Coffey RJ. Boivin GP, et al. Among authors: godfrey vl. Gastroenterology. 2003 Mar;124(3):762-77. doi: 10.1053/gast.2003.50094. Gastroenterology. 2003. PMID: 12612914 Review. No abstract available.
The Mutant Mouse Resource and Research Center (MMRRC): the NIH-supported National Public Repository and Distribution Archive of Mutant Mouse Models in the USA.
Amos-Landgraf J, Franklin C, Godfrey V, Grieder F, Grimsrud K, Korf I, Lutz C, Magnuson T, Mirochnitchenko O, Patel S, Reinholdt L, Lloyd KCK. Amos-Landgraf J, et al. Among authors: godfrey v. Mamm Genome. 2022 Mar;33(1):203-212. doi: 10.1007/s00335-021-09894-0. Epub 2021 Jul 27. Mamm Genome. 2022. PMID: 34313795 Free PMC article. Review.
Modeling-Enabled Characterization of Novel NLRX1 Ligands.
Lu P, Hontecillas R, Abedi V, Kale S, Leber A, Heltzel C, Langowski M, Godfrey V, Philipson C, Tubau-Juni N, Carbo A, Girardin S, Uren A, Bassaganya-Riera J. Lu P, et al. Among authors: godfrey v. PLoS One. 2015 Dec 29;10(12):e0145420. doi: 10.1371/journal.pone.0145420. eCollection 2015. PLoS One. 2015. PMID: 26714018 Free PMC article.
96 results